Mr. Antti Näykki Appointed as Business Development Director at Bittium
Press release
Free for publication on April 25, 2019 at 11am (CEST +1)
Mr. Antti Näykki Appointed as Business Development Director at Bittium
Mr. Antti Näykki (42), B.Eng. embedded systems, has been appointed as Director, Business Development at Bittium Corporation as of April 29, 2019. Mr. Näykki transfers to Bittium from Jutel Oy, where he worked as the Managing Director of the company. He has long experience in sustainable development and managing of businesses. Before that, Mr. Näykki has been in several sales and management positions at e.g. Polystar T&M, Exfo and Nethawk. In his business development duties at Bittium, he will report to Mr. Hannu Huttunen, CEO of Bittium Corporation.
“During the last few years, Bittium has been investing in development of own products and solutions, seeking growth to develop its international business. In 2018, we made significant international breakthroughs in bringing our products and services to the international markets, and we were able to get back on growth track. We are delighted to be able to welcome Mr. Näykki warmly to our team at this stage of our business development. He has years of experience in developing businesses and executing strategic projects,” says Hannu Huttunen, CEO of Bittium Corporation.
Oulu, April 25, 2019
Bittium Corporation
Further information:
Hannu Huttunen
CEO
Tel. + 358 40 344 5466
Distribution:
Main media
Bittium
Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2018 were EUR 62.8 million and operating profit was EUR 2.8 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com